Search Results

Filter
  • 1-10 of  43,730 results for ""FORMOTEROL""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Beclometasone Dipropionate/Formoterol Fumarate is Similarly Effective to Budesonide/Formoterol Fumarate in Chinese Patients with COPD: The FORSYYN Double-Blind, Randomised Study.

  • Authors : Wen F; Department of Respiratory and Critical Care Medicine, West China Hospital, Chengdu, China.; Wu Y

Subjects: Beclomethasone*/Beclomethasone*/Beclomethasone*/therapeutic use ; Beclomethasone*/Beclomethasone*/Beclomethasone*/administration & dosage ; Formoterol Fumarate*/Formoterol Fumarate*/Formoterol Fumarate*/therapeutic use

  • Source: COPD [COPD] 2024 Dec; Vol. 21 (1), pp. 2425157. Date of Electronic Publication: 2024 Nov 11.Publisher: Informa Healthcare Country of Publication: England NLM ID: 101211769 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The β 2 -adrenergic receptor agonist formoterol attenuates necrosis and apoptosis in the rat myocardium under experimental stress-induced cardiac injury.

  • Authors : Naryzhnaya NV; Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia, 111a, Kievskaya str., Tomsk, 634012, Russian Federation.; Logvinov SV

Subjects: Apoptosis*/Apoptosis*/Apoptosis*/drug effects ; Formoterol Fumarate*/Formoterol Fumarate*/Formoterol Fumarate*/pharmacology ; Adrenergic beta-2 Receptor Agonists*/Adrenergic beta-2 Receptor Agonists*/Adrenergic beta-2 Receptor Agonists*/pharmacology

  • Source: Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2024 Dec; Vol. 38 (6), pp. 1116-1130. Date of Electronic Publication: 2024 Jul 02.Publisher: Blackwell Science Country of Publication: England NLM ID: 8710411 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Influence of β 2 -adrenergic selective agonist formoterol on the motor unit of a mouse model of a congenital myasthenic syndrome with complete VAChT deletion.

  • Authors : Rossi L; Departamento de Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.; Mota BI

Subjects: Myasthenic Syndromes, Congenital*/Myasthenic Syndromes, Congenital*/Myasthenic Syndromes, Congenital*/drug therapy ; Myasthenic Syndromes, Congenital*/Myasthenic Syndromes, Congenital*/Myasthenic Syndromes, Congenital*/genetics ; Formoterol Fumarate*/Formoterol Fumarate*/Formoterol Fumarate*/pharmacology

  • Source: Neuropharmacology [Neuropharmacology] 2024 Dec 01; Vol. 260, pp. 110116. Date of Electronic Publication: 2024 Aug 14.Publisher: Pergamon Press Country of Publication: England NLM ID: 0236217 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The carbon footprint of as-needed budesonide/formoterol in mild asthma: a post hoc analysis.

  • Authors : Hatter L; Medical Research Institute of New Zealand, Wellington, New Zealand .; School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand.

Subjects: Asthma*/Asthma*/Asthma*/drug therapy ; Budesonide*/Budesonide*/Budesonide*/administration & dosage ; Carbon Footprint*

  • Source: The European respiratory journal [Eur Respir J] 2024 Jul 11; Vol. 64 (1). Date of Electronic Publication: 2024 Jul 11 (Print Publication: 2024).Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet

Record details

×
Academic Journal

Formoterol dynamically alters endocannabinoid tone in the periaqueductal gray inducing headache.

  • Authors : Peterson IL; Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, United States.; Liktor-Busa E

Subjects: Endocannabinoids*/Endocannabinoids*/Endocannabinoids*/metabolism ; Periaqueductal Gray*/Periaqueductal Gray*/Periaqueductal Gray*/metabolism ; Periaqueductal Gray*/Periaqueductal Gray*/Periaqueductal Gray*/drug effects

  • Source: The journal of headache and pain [J Headache Pain] 2024 Nov 19; Vol. 25 (1), pp. 200. Date of Electronic Publication: 2024 Nov 19.Publisher: BioMed Central Country of Publication: England NLM ID: 100940562 Publication Model: Electronic Cited Medium: Internet ISSN: 1129-2377

Record details

×
Academic Journal

Effects of inhaled beclometasone dipropionate/formoterol fumarate/glycopyrronium vs. beclometasone dipropionate/formoterol fumarate and placebo on lung hyperinflation and exercise endurance in chronic obstructive pulmonary disease: a randomised controlled trial.

  • Authors : Watz H; Velocity Clinical Research Grosshansdorf, Airway Research Center North (ARCN), Formerly Pulmonary Research Institute at Lung Clinic Grosshansdorf, Member of the German Center for Lung Research (DZL), Wöhrendamm 80, 22927, Grosshansdorf, Germany. .; Kirsten AM

Subjects: Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/drug therapy ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/physiopathology ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/diagnosis

  • Source: Respiratory research [Respir Res] 2024 Oct 17; Vol. 25 (1), pp. 378. Date of Electronic Publication: 2024 Oct 17.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Formoterol Reduces the Pro-Inflammatory Phenotype by Enhancing the Activity of Glutaminase in Monocyte-Derived Macrophages in the CVB3-Induced Viral Myocarditis.

  • Authors : Li QL; Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.; Xie HB

Subjects: Formoterol Fumarate*/Formoterol Fumarate*/Formoterol Fumarate*/pharmacology ; Myocarditis*/Myocarditis*/Myocarditis*/drug therapy ; Myocarditis*/Myocarditis*/Myocarditis*/virology

  • Source: Immunity, inflammation and disease [Immun Inflamm Dis] 2024 Nov; Vol. 12 (11), pp. e70073.Publisher: John Wiley and Sons Ltd Country of Publication: England NLM ID: 101635460 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

β 2 -adrenoceptor agonist formoterol attenuates NLRP3 inflammasome activation and GSDMD-mediated pyroptosis in microglia through enhancing IκBα/NF-κB inhibition, SQSTM1/p62-dependent selective autophagy and ESCRT-III-mediated plasma membrane repair.

  • Authors : Erdem M; Department of Medical Biochemistry, Faculty of Medicine, Malatya Turgut Özal University, Malatya 44900, Turkey; Department of Medical Biochemistry, Graduate School of Medical Science, Karadeniz Technical University, Trabzon 61080, Turkey. Electronic address: .

Subjects: NLR Family, Pyrin Domain-Containing 3 Protein*/NLR Family, Pyrin Domain-Containing 3 Protein*/NLR Family, Pyrin Domain-Containing 3 Protein*/metabolism ; Microglia*/Microglia*/Microglia*/drug effects ; Microglia*/Microglia*/Microglia*/metabolism

  • Source: Molecular and cellular neurosciences [Mol Cell Neurosci] 2024 Sep; Vol. 130, pp. 103956. Date of Electronic Publication: 2024 Aug 02.Publisher: Academic Press Country of Publication: United States NLM ID: 9100095 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

The evidence base for ICS/formoterol maintenance and reliever therapy in severe asthma.

  • Authors : Beasley R; Medical Research Institute of New Zealand, Wellington, New Zealand .; Noble J

Subjects: Asthma*/Asthma*/Asthma*/drug therapy ; Formoterol Fumarate*/Formoterol Fumarate*/Formoterol Fumarate*/administration & dosage ; Formoterol Fumarate*/Formoterol Fumarate*/Formoterol Fumarate*/therapeutic use

  • Source: The European respiratory journal [Eur Respir J] 2024 Jun 20; Vol. 63 (6). Date of Electronic Publication: 2024 Jun 20 (Print Publication: 2024).Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet

Record details

×
Academic Journal

Evaluating the pharmacokinetics of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurised metered-dose inhaler using a low global warming potential propellant.

  • Authors : Rony F; Global Clinical Development, Chiesi SAS, Bois Colombes, France. Electronic address: .; Cortellini M

Subjects: Beclomethasone*/Beclomethasone*/Beclomethasone*/pharmacokinetics ; Beclomethasone*/Beclomethasone*/Beclomethasone*/administration & dosage ; Formoterol Fumarate*/Formoterol Fumarate*/Formoterol Fumarate*/pharmacokinetics

  • Source: Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2024 Jun; Vol. 85, pp. 102299. Date of Electronic Publication: 2024 Apr 23.Publisher: Academic Press Country of Publication: England NLM ID: 9715279 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  43,730 results for ""FORMOTEROL""